Dados B3 › QUSW3 × OIBR3
QUSW3 × OIBR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | QUSW3 | OIBR3 | year |
|---|---|---|---|
| ROE | 19.7%! | -243.5% | 2021 |
| ROIC | 26.1%! | -91.3%! | 2022 |
| ROA | 9.1%! | -212.9% | 2025 |
| Gross margin | 100.0%! | -52.3% | 2025 |
| EBIT margin | 60.7%! | -176.4%! | 2025 |
| Net margin | 39.2%! | -1,399.8% | 2025 |
| Net debt/EBITDA | 0.68x! | 11.73x | 2021 |
| Current ratio | 1.03x! | 1.12x | 2025 |
| Revenue growth (1y) | -3.1%! | -18.3% | 2025 |
| Revenue growth (5y CAGR) | -12.7%! | -25.0% | 2025 |
| Piotroski F-Score | 4/9! | 4/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | QUSW3 | OIBR3 | year |
|---|---|---|---|
| P/E | — | 0.00x | None × 2024 |
| P/B | — | — | None × 2024 |
| EV/EBITDA | — | — | None × 2024 |
| FCF yield | — | -352,559.1% | None × 2024 |
Numbers on this page are live. Data version 2026-10-18-pl-classe-versoes · page generated 2026-10-24 01:49 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-18-pl-classe-versoes · page generated 2026-10-24 01:49 UTC. If this does not match /saude, you are reading a cached copy.